Vincenza I. Bartl
The Agent That Works Harder After The Closing Papers Are Signed.
Tuesday, August 8, 2017
Amgen Remains A Standout Among Biotechs
Amgen's Repatha is believed to have potential sales of $2 billion by 2020
from Forbes Real Time http://www.forbes.com/sites/genemarcial/2017/08/08/amgen-remains-a-standout-among-biotechs/
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment